logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

ZHOU HEI YA (01458) repurchased 18,000 shares at a cost of HKD 22,900 on September 4.

date
17:55 04/09/2026
avatar
GMT Eight
Zhou HeiYa (01458) announced that on September 4, 2026, the company spent HK$22,900 to repurchase 18,000 shares, with a repurchase price of HK$1.27 to HK$1.275 per share.
Zhou Hei Ya (01458) announced that on September 4, 2026, the company invested HKD 22,900 to buy back 18,000 shares, with a repurchase price of HKD 1.27-1.275 per share.
Related Articles
HK Stock
ZHAOKE OPHTH-B(06622): The phase II study of Carbocisteine bromide and memantine eye drops (YUVEZZI) in Chinese presbyopia patients met the primary endpoint.
HK Stock
IMMUNEONCO-B (01541) spent HKD 155,400 on September 4 to repurchase 44,800 shares.
China Stock
Hangzhou Guotai Environmental Protection Technology (301203.SZ) plans to invest approximately 808 million yuan to construct a project for the recycling of new energy materials and the production of battery materials.
ZHAOKE OPHTH-B(06622): The phase II study of Carbocisteine bromide and memantine eye drops (YUVEZZI) in Chinese presbyopia patients met the primary endpoint.
HK Stock
IMMUNEONCO-B (01541) spent HKD 155,400 on September 4 to repurchase 44,800 shares.
HK Stock
Hangzhou Guotai Environmental Protection Technology (301203.SZ) plans to invest approximately 808 million yuan to construct a project for the recycling of new energy materials and the production of battery materials.
China Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.